CHINAAMC Hang Seng Biotech ETF (HKG:3069)
Hong Kong · Delayed Price · Currency is HKD 15.68
+0.09 (0.58%)
At close: Apr 2, 2026
35.06% (1Y)
| Assets | 1.99B |
| Expense Ratio | 0.75% |
| PE Ratio | 28.07 |
| Dividend (ttm) | 0.05 |
| Dividend Yield | 0.32% |
| Ex-Dividend Date | Dec 18, 2025 |
| Payout Frequency | Annual |
| Payout Ratio | 8.95% |
| 1-Year Return | +35.52% |
| Volume | 11,840,510 |
| Open | 15.59 |
| Previous Close | 15.59 |
| Day's Range | 15.40 - 15.93 |
| 52-Week Low | 8.75 |
| 52-Week High | 18.62 |
| Beta | 0.65 |
| Holdings | 10 |
| Inception Date | Mar 18, 2021 |
About 3069
CHINAAMC Hang Seng Biotech ETF is headquartered in Beijing, China.
Asset Class Equity
Category Health Care
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 3069
Provider ChinaAMC
Index Tracked Hang Seng Biotech Index - HKD - Benchmark TR Net
Performance
3069 had a total return of 35.52% in the past year, including dividends. Since the fund's inception, the average annual return has been -8.21%.
Top Holdings
67.71% of assets| Name | Symbol | Weight |
|---|---|---|
| WuXi Biologics (Cayman) Inc. | 2269 | 10.46% |
| BeOne Medicines AG | 6160 | 9.35% |
| Innovent Biologics, Inc. | 1801 | 8.48% |
| Akeso, Inc. | 9926 | 8.07% |
| CSPC Pharmaceutical Group Limited | 1093 | 6.59% |
| Sino Biopharmaceutical Limited | 1177 | 6.18% |
| Hansoh Pharmaceutical Group Company Limited | 3692 | 5.30% |
| 3SBio Inc. | 1530 | 4.56% |
| WuXi AppTec Co., Ltd. | 2359 | 4.48% |
| Citigroup Global Markets Holdings Inc. | n/a | 4.24% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 18, 2025 | 0.050 HKD | Dec 31, 2025 |
| Dec 18, 2024 | 0.060 HKD | Dec 31, 2024 |
| Dec 18, 2023 | 0.030 HKD | Dec 29, 2023 |
| Dec 19, 2022 | 0.040 HKD | Dec 30, 2022 |